ERBB4 overexpression activates a novel ERBB4-PI3K-Akt-FAK-Rac1 pathway that stimulates migration and invasion of ES cells, and confers metastatic capacity in vivo. The gene discussed is RAC1; the disease is Ewing sarcoma.